Келоидные рубцы. Современные аспекты диагностики и лечения

1. Child FJ, Fuller LC, Higging EM, Vivier DU. A study of the spectrum of skin disease occurring in a black population in South-East London. Br J Dermatol. 1999;141:5127.
2. Omo-Dare P. Yoruban contributions to the literature on keloids. Natl Med Assoc. 1973;65:367-406.
3. Pruimboom T, Scheltinga MR. Keloid Formation due to Repetitive Mammographies. Case Rep Dermatol. 2018;10(3):257-62. DOI:10.1159/000495020
4. Addison T. On the Keloid of Alibert, and on True Keloid. Med Chir Trans. 1854;37:27-47. DOI:10.1177/095952875403700106
5. Hutchinson J. London Hospital Reports. 1864;1:92.
6. Unna PG. The Histopathology of the Diseases of the Skin. NY: McMillan Co., 1896; p. 839.
7. Thorn I. Ueber spontanes keloid. Arch Klin Chir. 1895;51:618-36.
8. Asboe-Hansen G. Hypertrophic scars and keloids. Etiology, pathogenesis and dermatologic therapy. Dermatologica. 1960;120:178-84. PMID: 13794646.
9. Taussig LR. The treatment of keloids with radium. Cal State J Med. 1923;21(12):520-2. PMID: 18739168; PMCID: PMC1517783. 
10. Asawanonda P, Khoo LS, Fitzpatrick TB, Taylor CR. UV-A1 for keloid. Arch Dermatol. 1999;135(3):348-9. DOI:10.1001/archderm.135.3.348
11. Louw L. Keloids in rural black South Africans. Part 1: general overview and essential fatty acid hypotheses for keloid formation and prevention. Prostaglandins Leukot Essent Fatty Acids. 2000;63(5):237-45. DOI:10.1054/plef.2000.0207
12. Письменскова А.В. Келоидные рубцы. М.: РАЕН, 2012 [Pismenskova AV. Keloid scars. Moscow: RANS, 2012 (in Russian)].
13. Takahashi PY, Kiemele LJ, Jones JP Jr. Wound care for elderly patients: advances and clinical applications for practicing physicians. Mayo Clin Proc. 2004;79(2):260-7. DOI:10.4065/79.2.260
14. Young VL, Hutchison J. Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys. Plast Reconstr Surg. 2009;124(1):256-65. DOI:10.1097/PRS.0b013e3181a80747
15. Robert R, Meyer W, Bishop S, et al. Disfiguring burn scars and adolescent self-esteem. Burns. 1999;25(7):581-5. DOI:10.1016/s0305-4179(99)00065-0
16. Шафранов В.В., Таганов А.В., Гладько В.В., и др. Дифференциальная диагностика келоидных и гипертрофических рубцов, основанная на различиях в кожной чувствительности. Клиническая дерматология и венерология. 2011;9(2):20-2 [Shafranov VV, Taganov AV, Glad'ko VV, et al. Differentsial'naia diagnostika keloidnykh i gipertroficheskikh rubtsov, osnovannaia na razlichiiakh v kozhnoi chuvstvitel'nosti. Klinicheskaia dermatologiia i venerologiia. 2011;9(2):20-2 (in Russian)].
17. Ginsberg BA, Calderon M, Seminara NM, Day D. A potential role for the dermatologist in the physical transformation of transgender people: a survey of attitudes and practices within the transgender community. J Am Acad Dermatol. 2016;74:303-8. 
18. Lee HJ, Jang YJ. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. Int J Mol Sci. 2018;19(3):711. DOI:10.3390/ijms19030711
19. Ogawa R, Akita S, Akaishi S, et al. Diagnosis and Treatment of Keloids and Hypertrophic Scars-Japan Scar Workshop Consensus Document 2018. Burns Trauma. 2019;7:39. DOI:10.1186/s41038-019-0175-y
20. Coop CA, Schaefer SM, England RW. Extensive keloid formation and progression after each vaccination. Hum Vaccin. 2007;3(4):127-9. DOI:10.4161/hv.3.4.4140
21. Fernández-Crehuet P, Fernández-Crehuet JL, Benitez-Camacho F. Successful cosmetic outcome of earlobe keloid after surgical excision and topical imiquimod 5. Dermatol Ther. 2020;33(6):e13815. DOI:10.1111/dth.13815 
22. Kirby W, Alston DB, Chen AH. The Incidence of Hypertrophic Scarring and Keloid Formation Following Laser Tattoo Removal with a Quality-switched Nd: YAG Laser. J Clin Aesthet Dermatol. 2016;9(5):43-7. PMID: 27386045; PMCID: PMC4928479.
23. Holbrook J, Minocha J, Laumann A. Body piercing: complications and prevention of health risks. Am J Clin Dermatol. 2012;13(1):1-17. DOI:10.2165/11593220-000000000-00000
24. Ogawa R. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis. Int J Mol Sci. 2017;18(3):606. DOI:10.3390/ijms18030606 
25. Jumper N, Paus R, Bayat A. Functional histopathology of keloid disease. Histol Histopathol. 2015;30(9):1033-57. DOI:10.14670/HH-11-624
26. Shaheen A, Khaddam J, Kesh F. Risk factors of keloids in Syrians. BMC Dermatol. 2016;16(1):13. DOI:10.1186/s12895-016-0050-5 
27. Bayat A, Arscott G, Ollier WE, et al. Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg. 2005;58(1):28-37. DOI:10.1016/j.bjps.2004.04.024
28. Olaitan PB, Olabanji JK, Oladele AO, Oseni GA. Symptomatology of keloids in Africans. Sierra Leone Journal of Biomedical Research. 2013;5:29-33.
29. Halim AS, Emami A, Salahshourifar I, Kannan TP. Keloid scarring: understanding the genetic basis, advances, and prospects. Arch Plast Surg. 2012;39(3):184-9. DOI:10.5999/aps.2012.39.3.184 
30. Sun LM, Wang KH, Lee YC. Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: a nationwide population-based study. Arch Dermatol Res. 2014;306(9):803-8. DOI:10.1007/s00403-014-1491-5
31. Clark JA, Turner ML, Howard L, et al. Description of familial keloids in five pedigrees: evidence for autosomal dominant inheritance and phenotypic heterogeneity. BMC Dermatol. 2009;9:8. DOI:10.1186/1471-5945-9-8
32. Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res. 2010;302(5):319-39. DOI:10.1007/s00403-009-1014-y
33. Roseborough IE, Grevious MA, Lee RC. Prevention and treatment of excessive dermal scarring. J Natl Med Assoc. 2004;96(1):108-16. 
34. Nakashima M, Chung S, Takahashi A, et al. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet. 2010;42(9):768-71. DOI:10.1038/ng.645
35. Chike-Obi CJ, Cole PD, Brissett AE. Keloids: pathogenesis, clinical features, and management. Semin Plast Surg. 2009;23(3):178-84. DOI:10.1055/s-0029-1224797
36. Lane JE, Waller JL, Davis LS. Relationship between age of ear piercing and keloid formation. Pediatrics. 2005;115(5):1312-4. DOI:10.1542/peds.2004-1085
37. Bayat A, Walter JM, Bock O, et al. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta(3) gene. Br J Plast Surg. 2005;58(7):914-21.
38. Cohen IK, McCoy BJ, Mohanakumar T, Diegelmann RF. Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg. 1979;63:689-95.
39. Philandrianos C, Kerfant N, Jaloux C Jr., et al. Keloid scars (part I): Clinical presentation, epidemiology, histology and pathogenesis. Ann Chir Plast Esthet. 2016;61(2):128-35 (In French). DOI:10.1016/j.anplas.2015.09.005
40. Park TH, Chang CH. Keloid recurrence in pregnancy. Aesthetic Plast Surg. 2012;36(5):1271-2. DOI:10.1007/s00266-012-9947-5 
41. Koonin AJ. The aetiology of keloids: A review of the literature and a new hypothesis. S Afr Med J. 1964;38:913-6.
42. Monstafa MF, Abdel AF. The presumptive of the presumptive evidence of pregnancy estrogen on keloid growth: case report. Plast Recon Surg. 1975;56:450-3.
43. Линарес Х.А. Лечение гипертрофий: спорные и этиопатогенетические аспекты. В: Х.Ф. Карваял, Д.Х. Паркс. Ожоги у детей. Пер. с англ. М.: Медицина, 1990 [Linares HA. Treatment of hypertrophies: controversial and etiopathogenetic aspects. In: HF Carvajal, DH Parks. Burns in children. Transl. from English. Moscow: Medicine, 1990 (in Russian)].
44. Holmstrand K, Longacre JL, de Stefano QA. The ultra structure of collagen in skin, scars and keloids. Plast Reconstr Surg. 1961;27:597-607.
45. Steinbrech DS, Mehrara BJ, Chau D, et al. Hypoxia upregulates VEGF production in keloid fibroblasts. Ann Plast Surg. 1999;42(5):514-9.
46. Kischer CW. Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg. 1983;71:821-5.
47. Peacock EE. Pharmacologic control of surface scarring in human beings. Ann Surg. 1981;193:592-7.
48. Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician. 2009;80(3):253-60. PMID: 19621835.
49. Короткий Н.Г., Шафранов В.В., Таганов А.В., Борхунова Е.Н. СВЧ-криогенный метод лечения келоидных рубцов в детской дерматологической практике. Рос. журн. кожных и венерических болезней. 1998;4:30-5 [Korotkii NG, Shafranov VV, Taganov AV, Borkhunova EN. SVCh-kriogennyi metod lecheniia keloidnykh rubtsov v detskoi dermatologicheskoi praktike. Ros zhurn kozhnykh i venericheskikh boleznei. 1998;4:30-5 (in Russian)].
50. Мусотэ Т.А., Куттер Р.Д., Голд М.Н., Хоббс Р. Международные рекомендации по ведению больных с рубцами (для международной комиссии экспертов по лечению рубцов). Пер. с англ. Клин. дерматол. 2006;1:92-6 [Musote TA, Kutter RD, Gold MN, Khobbs R. Mezhdunarodnye rekomendatsii po vedeniiu bol'nykh s rubtsami (dlia mezhdunarodnoi komissii ekspertov po lecheniiu rubtsov). Transl from Engl. Klin. dermatol. 2006;1:92-6 (in Russian)].
51. Ellitsgaard V, Ellitsgaard N. Hypertrophic scars and keloids: a recurrent problem revisited. Acta Chir Plast. 1997;39(3):69-77.
52. Slavkin HC. The body's skin frontier and the challenges of wound healing: keloids. Am Dent Assoc. 2000;131(3):362-5.
53. Таганов А.В. Лечение келоидных рубцов у детей СВЧ-криогенным методом и его клинико-морфологическое обоснование. Дис. … канд. мед. наук. М., 1999 [Taganov AV. Lechenie keloidnykh rubtsov u detei SVCh-kriogennym metodom i ego kliniko-morfologicheskoe obosnovanie. Dis. … kand. med. nauk. Moscow, 1999 (in Russian)].
54. Ueda K, Furuya E, Yasuda Y, et al. Keloids have continuous high metabolic activity. Plast Reconstr Surg. 1999;104:694.
55. Chike-Obi CJ, Cole PD, Brissett AE. Keloids: Pathogenesis, clinical features and management. Semin Plast Surg. 2009;23:178-84.
56. Mustoe TA, Cooter RD, Gold M. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-71.
57. Blackburn WR, Cosman B. Histologie basis of keloid and hypertrophic scar differentiation. Arch Pathol. 1996;82:65-71.
58. Павлова М.Н. Морфогенез келоидных рубцов у ожоговых больных. Дис. … д-ра мед. наук. М., 1970 [Pavlova MN. Morfogenez keloidnykh rubtsov u ozhogovykh bol'nykh. Dis. … d-ra med. nauk. Moscow, 1970 (in Russian)].
59. Beausang E, Floyd H, Dunn K, et al. A new quantitative scale for clinical scar assessment. Plast Reconstr Surg. 1998;102:1954-61.
60. Westerhof W. CIE colorimetry. In: Ed. J Serup, GBE Jemec. Handbook of non-invasive methods and the skin. CRC Press: Boca Raton, Fla., 1995; p. 385-97.
61. Ketchum LD, Smith J, Robinson DW, Masters FW. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg. 1966;38(3):209-18. DOI:10.1097/00006534-196609000-00005
62. Roques C, Teot L, Frasson N, Meaume S. PRIMOS: an optical system that produces three-dimensional measurements of skin surfaces. J Wound Care. 2003;12:62-4.
63. Draaijers LJ, Botman YA, Tempelman FR, et al. Skin elasticity meter or subjective evaluation in scars: a reliability assessment. Burns. 2004;30(2):109-14. DOI:10.1016/j.burns.2003.09.003
64. Sullivan T, Smith J, Kermode J, et al. Rating the Burn Scar. J Burn Care Rehabil. 1990;11(3):256-60. DOI:10.1097/00004630-199005000-00014
65. Yeong EK, Mann R, Engrav LH, et al. Improved burn scar assessment with use of a new scar-rating scale. J Burn Care Rehabil. 1997;18:353-5.
66. Kantor J. Reliability and Photographic Equivalency of the Scar Cosmesis Assessment and Rating (SCAR) Scale, an Outcome Measure for Postoperative Scars. JAMA Dermatol. 2017;153(1):55-60. DOI:10.1001/jamadermatol.2016.3757
67. Singer AJ, Arora B, Dagum A, et al. Development and Validation of a Novel Scar Evaluation Scale. Plast Recon Sur. 2007;120(7):1892-7. DOI:10.1097/01.prs.0000287275.15511.10
68. Полукаров Н., Голубев В. Современные методы лечения патологических рубцов кожи и рубцовых осложнений. Врач. 2007;2:59-62.
69. Furtado F, Hochman B, Ferreira LM. Evaluating keloid recurrence after surgical excision with prospective longitudinal scar assessment scales. JPRAS. 2012;65(7):175-81.
70. Alster TS, West TB. Treatment of scars: a review. Ann Plast Surg. 1997;39(4):418-32. 
71. Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumpedpulsed-dyelaser. Lancet. 1995;345(8959):1198-2000.
72. Белоусов А.Е. Очерки пластической хирургии. Т. 1. Рубцы и их коррекция. СПб., 2005 [Belousov AE. Essays on Plastic Surgery. Vol. 1. Scars and their correction. Saint Petersburg, 2005 (in Russian)].
73. Sherris DA, Larrabee WF, Murakami CS. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am. 1995;28:1057-68.
74. Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg. 1996;22:1267-130.
75. Berman B, Bieley HC. Keloids. J Am Acad Dermatol. 1995;33:117-23.
76. Shin JY, Lee JW, Roh SG, et al. A Comparison of the Effectiveness of Triamcinolone and Radiation Therapy for Ear Keloids after Surgical Excision: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2016;137(6):1718-25. DOI:10.1097/PRS.0000000000002165
77. Шафранов В.В., Резницкий В.Г. Некоторые проблемы и перспективы использования низких температур в детской хирургии. Вестник АМН СССР. 1984;9 [Shafranov VV, Reznitskii VG. Nekotorye problemy i perspektivy ispol'zovaniia nizkikh temperatur v detskoi khirurgii. Vestnik AMN SSSR. 1984;9 (in Russian)]. 
78. Sproat JE, Dalcin A, Weitauer N, Roberts RS. Hypertrophic sternal scars: silicone gel sheeting versus kenalog injection treatment. Plast Reconstr Surg. 1992;90:988-92.
79. Friedman SJ, Butler DF, Pittelkow MR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy: Report of two cases and review of the literature. J Am Acad Dermatol. 1988;19:537-41.
80. Mann T, Scherner C, Röhm KH, Kolbe L. Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase. Int J Mol Sci. 2018;19(3):690. DOI:10.3390/ijms19030690 
81. Mann T, Gerwat W, Batzer J, et al. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase. J Invest Dermatol. 2018;138(7):1601-8. DOI:10.1016/j.jid.2018.01.019
82. Arrowitz C, Schoelermann AM, Mann T, et al. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma. J Invest Dermatol. 2019;139(8):1691-8.e6. DOI:10.1016/j.jid.2019.02.013
83. Krupashankar DS. IADVL Dermatosurgery Task Force. Standard guidelines of care: CO2 laser for removal of benign skin lesions and resurfacing. Indian J Dermatol Venerol Leprol. 2008;74:61-7.
84. Weinhammer AP, Shields BE, Keenan T. Intralesional corticosteroid-induced hypopigmentation and atrophy. Dermatol Online J. 2020;26(1):13030/qt0bj81707. PMID: 32155037.
85. Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg. 1995;21(8):685-7. DOI:10.1111/j.1524-4725.1995.tb00270.x
86. Wittenberg GP, Fabian BG, Bogomilsky JL. Prospective single-blind, randomised controlled study to assess the efficacy of the 585-nm flashlamp pumped pulsed-dye laser and silicone gel sheeting in hypertrophic scar treatment. Arch Dermatol. 1999;135(9):1049-55.
87. Alster TS, Tanzi EL. Hypertrophic scars and keloids etiology and management. Am J Clin Dermatol. 2003;4:235-43.
88. Mankowski P, Kanevsky J, Tomlinson J, et al. Optimizing Radiotherapy for Keloids: A Meta-Analysis Systematic Review Comparing Recurrence Rates Between Different Radiation Modalities. Ann Plast Surg. 2017;78(4):403-11. DOI:10.1097/SAP.0000000000000989
89. Van de Kar AL, Kreulen M, van Zuijlen PP, Oldenburger F. The results of surgical excision and adjuvant irradiation for therapy-resistant keloids: A prospective clinical outcome study. Plast Reconstr Surg. 2007;119:2248-54.
90. Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: Retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111:547-53.
91. De las Alas JM, Siripunvarapon AH, Dofitas BL. Pulsed dye laser for the treatment of keloid and hypertrophic scars: a systematic review. Expert Rev Med Devices. 2012;9(6):641-50. DOI:10.1586/erd.12.56
92. Ellis MM, Jones LR, Siddiqui F, et al. The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis. Dermatol Surg. 2020;46(8):1054-59. DOI:10.1097/DSS.0000000000002362
93. Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg. 1991;27(2):164-78. DOI:10.1097/00000637-199108000-00012 
94. Clugston PA, Vistnes MD, Perry LC. Evaluation of silicone-gel sheeting on early wound healing of linear incisions. Ann Plast Surg. 1995;34:12-5.
95. Roderick BJ, Joyce D, Wasil K, et al. Splints and scar management for acute and reconstructive burn care. Clin Plast Surg. 2000;1:71-85.
96. Monstrey S, Middelkoop E, Vranckx JJ, et al. Updated Scar Management Practical Guidelines: Non-invasive and invasive measures. J Plast Reconstr Aesthet Surg. 2014;67(8):1017-25. DOI:10.1016/j.bjps.2014.04.011
97. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol. 1994;30:506-7.
98. Katz BE. Silicone gel sheeting in scar therapy. Cutis. 1995;56:65-7.
99. Tredget EE, Wang R, Shen Q, et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res. 2000;20:143-51.
100. Grandstein RD, Rook A, Flotte TJ. A controlled trial of intralesional recombinant interferon у in the treatment of keloid scarring. Arch Dermatol. 1990;126:1285-302.
101. Berman B, Dunan MR. Short-term keloid treatment in vivo with human interferon α 2b results in a selective and persistent normalization of keloid fibroblast collagen, glycosaminoglycan and collagenase production in vitro. J Am Acad Dermatol. 1989;21:694-702.
102. Goldan O, Weissman O, Regev E, et al. Treatment of postdermabrasion facial hypertrophic and keloid scars with intralesional 5-Fluorouracil injections. Aesthetic Plast Surg. 2008;32(2):389-92. DOI:10.1007/s00266-007-9109-3
103. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol. 2004;45(2):140-3. DOI:10.1111/j.1440-0960.2004.00072.x
104. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology. 2002;204(2):130-2. DOI:10.1159/000051830
105. Cosman B, Crikelair GF, Ju MC. The surgical treatment of keloids. Plast Reconstr Surg. 1961;27:335-58.
106. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg. 1999;25:224-32.
107. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: Comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nmflashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 1992;138:1149-55.
108. Bodokh I, Brun P. The treatment of keloids with intralesional Bleomycin. Ann Dermatol Venereol. 1996;123:791-4.
109. Шафранов В.В., Борхунова Е.Н., Таганов А.В., и др. Келоидные рубцы. Новые технологии лечения. Ч. 2. М.: РАЕН, 2009 [Shafranov VV, Borkhunova EN, Taganov AV, et al. Keloid scars. New treatment technologies. Part 2. Moscow: RANS, 2009 (in Russian)].
110. Цыганов Д.И. Теплофизические аспекты криохирургии. М.: РМА-ПО, 2005 [Tsyganov DI. Thermophysical aspects of cryosurgery. Moscow: RMA-PO, 2005 (in Russian)]. 
111. Цыганов Д.И., Шафранов В.В., Буторина А.В. Теоретические аспекты применения новых технических средств в криохирургии. Наука и технологии в России. 1998;6:20-1 [Tsyganov DI, Shafranov VV, Butorina AV. Teoreticheskie aspekty primeneniia novykh tekhnicheskikh sredstv v kriokhirurgii. Nauka i tekhnologii v Rossii. 1998;6:20-1 (in Russian)]. 
112. Шафранов В.В., Борхунова Е.Н., Таганов А.В., Короткий Н.Г. Келоидные рубцы у детей. Руководство для врачей. М.: Династия, 2006 [Shafranov VV, Borkhunova EN, Taganov AV, Korotkiy NG. Keloid Scars in Children. A Guide for Physicians. Moscow: Dynasty, 2006 (in Russian)].
113. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993;19(6):529-34.
114. Пачес А.И. Криогенный метод лечения опухолей головы и шеи. М., 1978 [Paches AI. Cryogenic method for the treatment of head and neck tumors. Moscow, 1978 (in Russian)]. 
115. Рикберг А.В., Трушкевич Л.И. О возможности усиления криоповреждения. В: Механизмы и криоповреждения биологических структур. Киев, 1976; c. 116-8 [Rikberg AV, Trushkevich LI. About the possibility of strengthening cryopreservation. In: Mechanisms and cryopreservation of biological structures. Kiev, 1976; p. 116-8 (in Russian)].
116. Борхунова Е.Н. Особенности репаративной регенерации тканей после криодеструкции, СВЧ-криодеструкции и СВЧ-деструкции. Дис. … д-ра мед. наук. М., 2004 [Borkhunova EN. Osobennosti reparativnoi regeneratsii tkanei posle kriodestruktsii, SVCh-kriodestruktsii i SVCh-destruktsii. Dis. … d-ra med. nauk. Moscow, 2004 (in Russian)].
117. Sizov VM, Pechenova TN, Volodina TG, et al. Changes in the structure of postburn keloid scars before and after cryotherapy. Vrach Delo. 1990;(9):95-7 (in Russian). PMID: 2284788.
118. Таганов А.В. Современные технологии в лечении рубцовых гипертрофий. Экспериментальное и клинико-морфологическое исследование. Дис …. д-ра мед. наук. М., 2010 [Taganov AV. Sovremennye tekhnologii v lechenii rubtsovykh gipertrofii. Eksperimental'noe i kliniko-morfologicheskoe issledovanie. Dis …. d-ra med. nauk. Moscow, 2010 (in Russian)]. 
119. Письменскова А.В. Лечение келоидных рубцов методом СВЧ-деструкции в дерматокосметологической практике. Дис. … канд. мед. наук. М., 2010 [Pis'menskova AV. Lechenie keloidnykh rubtsov metodom SVCh-destruktsii v dermatokosmetologicheskoi praktike. Dis. … kand. med. nauk. Moscow, 2010 (in Russian)].
120. Stewart CE, Kim JY. Application of mitomycin-C for head and neck keloids. Otolaryngol Head Neck Surg. 2006;135:946-50.

________________________________________________

1. Child FJ, Fuller LC, Higging EM, Vivier DU. A study of the spectrum of skin disease occurring in a black population in South-East London. Br J Dermatol. 1999;141:5127.
2. Omo-Dare P. Yoruban contributions to the literature on keloids. Natl Med Assoc. 1973;65:367-406.
3. Pruimboom T, Scheltinga MR. Keloid Formation due to Repetitive Mammographies. Case Rep Dermatol. 2018;10(3):257-62. DOI:10.1159/000495020
4. Addison T. On the Keloid of Alibert, and on True Keloid. Med Chir Trans. 1854;37:27-47. DOI:10.1177/095952875403700106
5. Hutchinson J. London Hospital Reports. 1864;1:92.
6. Unna PG. The Histopathology of the Diseases of the Skin. NY: McMillan Co., 1896; p. 839.
7. Thorn I. Ueber spontanes keloid. Arch Klin Chir. 1895;51:618-36.
8. Asboe-Hansen G. Hypertrophic scars and keloids. Etiology, pathogenesis and dermatologic therapy. Dermatologica. 1960;120:178-84. PMID: 13794646.
9. Taussig LR. The treatment of keloids with radium. Cal State J Med. 1923;21(12):520-2. PMID: 18739168; PMCID: PMC1517783. 
10. Asawanonda P, Khoo LS, Fitzpatrick TB, Taylor CR. UV-A1 for keloid. Arch Dermatol. 1999;135(3):348-9. DOI:10.1001/archderm.135.3.348
11. Louw L. Keloids in rural black South Africans. Part 1: general overview and essential fatty acid hypotheses for keloid formation and prevention. Prostaglandins Leukot Essent Fatty Acids. 2000;63(5):237-45. DOI:10.1054/plef.2000.0207
12. Pismenskova AV. Keloid scars. Moscow: RANS, 2012 (in Russian).
13. Takahashi PY, Kiemele LJ, Jones JP Jr. Wound care for elderly patients: advances and clinical applications for practicing physicians. Mayo Clin Proc. 2004;79(2):260-7. DOI:10.4065/79.2.260
14. Young VL, Hutchison J. Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys. Plast Reconstr Surg. 2009;124(1):256-65. DOI:10.1097/PRS.0b013e3181a80747
15. Robert R, Meyer W, Bishop S, et al. Disfiguring burn scars and adolescent self-esteem. Burns. 1999;25(7):581-5. DOI:10.1016/s0305-4179(99)00065-0
16. Shafranov VV, Taganov AV, Glad'ko VV, et al. Differentsial'naia diagnostika keloidnykh i gipertroficheskikh rubtsov, osnovannaia na razlichiiakh v kozhnoi chuvstvitel'nosti. Klinicheskaia dermatologiia i venerologiia. 2011;9(2):20-2 (in Russian).
17. Ginsberg BA, Calderon M, Seminara NM, Day D. A potential role for the dermatologist in the physical transformation of transgender people: a survey of attitudes and practices within the transgender community. J Am Acad Dermatol. 2016;74:303-8. 
18. Lee HJ, Jang YJ. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. Int J Mol Sci. 2018;19(3):711. DOI:10.3390/ijms19030711
19. Ogawa R, Akita S, Akaishi S, et al. Diagnosis and Treatment of Keloids and Hypertrophic Scars-Japan Scar Workshop Consensus Document 2018. Burns Trauma. 2019;7:39. DOI:10.1186/s41038-019-0175-y
20. Coop CA, Schaefer SM, England RW. Extensive keloid formation and progression after each vaccination. Hum Vaccin. 2007;3(4):127-9. DOI:10.4161/hv.3.4.4140
21. Fernández-Crehuet P, Fernández-Crehuet JL, Benitez-Camacho F. Successful cosmetic outcome of earlobe keloid after surgical excision and topical imiquimod 5. Dermatol Ther. 2020;33(6):e13815. DOI:10.1111/dth.13815 
22. Kirby W, Alston DB, Chen AH. The Incidence of Hypertrophic Scarring and Keloid Formation Following Laser Tattoo Removal with a Quality-switched Nd: YAG Laser. J Clin Aesthet Dermatol. 2016;9(5):43-7. PMID: 27386045; PMCID: PMC4928479.
23. Holbrook J, Minocha J, Laumann A. Body piercing: complications and prevention of health risks. Am J Clin Dermatol. 2012;13(1):1-17. DOI:10.2165/11593220-000000000-00000
24. Ogawa R. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis. Int J Mol Sci. 2017;18(3):606. DOI:10.3390/ijms18030606 
25. Jumper N, Paus R, Bayat A. Functional histopathology of keloid disease. Histol Histopathol. 2015;30(9):1033-57. DOI:10.14670/HH-11-624
26. Shaheen A, Khaddam J, Kesh F. Risk factors of keloids in Syrians. BMC Dermatol. 2016;16(1):13. DOI:10.1186/s12895-016-0050-5 
27. Bayat A, Arscott G, Ollier WE, et al. Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg. 2005;58(1):28-37. DOI:10.1016/j.bjps.2004.04.024
28. Olaitan PB, Olabanji JK, Oladele AO, Oseni GA. Symptomatology of keloids in Africans. Sierra Leone Journal of Biomedical Research. 2013;5:29-33.
29. Halim AS, Emami A, Salahshourifar I, Kannan TP. Keloid scarring: understanding the genetic basis, advances, and prospects. Arch Plast Surg. 2012;39(3):184-9. DOI:10.5999/aps.2012.39.3.184 
30. Sun LM, Wang KH, Lee YC. Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: a nationwide population-based study. Arch Dermatol Res. 2014;306(9):803-8. DOI:10.1007/s00403-014-1491-5
31. Clark JA, Turner ML, Howard L, et al. Description of familial keloids in five pedigrees: evidence for autosomal dominant inheritance and phenotypic heterogeneity. BMC Dermatol. 2009;9:8. DOI:10.1186/1471-5945-9-8
32. Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res. 2010;302(5):319-39. DOI:10.1007/s00403-009-1014-y
33. Roseborough IE, Grevious MA, Lee RC. Prevention and treatment of excessive dermal scarring. J Natl Med Assoc. 2004;96(1):108-16. 
34. Nakashima M, Chung S, Takahashi A, et al. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet. 2010;42(9):768-71. DOI:10.1038/ng.645
35. Chike-Obi CJ, Cole PD, Brissett AE. Keloids: pathogenesis, clinical features, and management. Semin Plast Surg. 2009;23(3):178-84. DOI:10.1055/s-0029-1224797
36. Lane JE, Waller JL, Davis LS. Relationship between age of ear piercing and keloid formation. Pediatrics. 2005;115(5):1312-4. DOI:10.1542/peds.2004-1085
37. Bayat A, Walter JM, Bock O, et al. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta(3) gene. Br J Plast Surg. 2005;58(7):914-21.
38. Cohen IK, McCoy BJ, Mohanakumar T, Diegelmann RF. Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg. 1979;63:689-95.
39. Philandrianos C, Kerfant N, Jaloux C Jr., et al. Keloid scars (part I): Clinical presentation, epidemiology, histology and pathogenesis. Ann Chir Plast Esthet. 2016;61(2):128-35 (In French). DOI:10.1016/j.anplas.2015.09.005
40. Park TH, Chang CH. Keloid recurrence in pregnancy. Aesthetic Plast Surg. 2012;36(5):1271-2. DOI:10.1007/s00266-012-9947-5 
41. Koonin AJ. The aetiology of keloids: A review of the literature and a new hypothesis. S Afr Med J. 1964;38:913-6.
42. Monstafa MF, Abdel AF. The presumptive of the presumptive evidence of pregnancy estrogen on keloid growth: case report. Plast Recon Surg. 1975;56:450-3.
43. Linares HA. Treatment of hypertrophies: controversial and etiopathogenetic aspects. In: HF Carvajal, DH Parks. Burns in children. Transl. from English. Moscow: Medicine, 1990 (in Russian).
44. Holmstrand K, Longacre JL, de Stefano QA. The ultra structure of collagen in skin, scars and keloids. Plast Reconstr Surg. 1961;27:597-607.
45. Steinbrech DS, Mehrara BJ, Chau D, et al. Hypoxia upregulates VEGF production in keloid fibroblasts. Ann Plast Surg. 1999;42(5):514-9.
46. Kischer CW. Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg. 1983;71:821-5.
47. Peacock EE. Pharmacologic control of surface scarring in human beings. Ann Surg. 1981;193:592-7.
48. Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician. 2009;80(3):253-60. PMID: 19621835.
49. Korotkii NG, Shafranov VV, Taganov AV, Borkhunova EN. SVCh-kriogennyi metod lecheniia keloidnykh rubtsov v detskoi dermatologicheskoi praktike. Ros zhurn kozhnykh i venericheskikh boleznei. 1998;4:30-5 (in Russian).
50. Musote TA, Kutter RD, Gold MN, Khobbs R. Mezhdunarodnye rekomendatsii po vedeniiu bol'nykh s rubtsami (dlia mezhdunarodnoi komissii ekspertov po lecheniiu rubtsov). Transl from Engl. Klin. dermatol. 2006;1:92-6 (in Russian).
51. Ellitsgaard V, Ellitsgaard N. Hypertrophic scars and keloids: a recurrent problem revisited. Acta Chir Plast. 1997;39(3):69-77.
52. Slavkin HC. The body's skin frontier and the challenges of wound healing: keloids. Am Dent Assoc. 2000;131(3):362-5.
53. Taganov AV. Lechenie keloidnykh rubtsov u detei SVCh-kriogennym metodom i ego kliniko-morfologicheskoe obosnovanie. Dis. … kand. med. nauk. Moscow, 1999 (in Russian).
54. Ueda K, Furuya E, Yasuda Y, et al. Keloids have continuous high metabolic activity. Plast Reconstr Surg. 1999;104:694.
55. Chike-Obi CJ, Cole PD, Brissett AE. Keloids: Pathogenesis, clinical features and management. Semin Plast Surg. 2009;23:178-84.
56. Mustoe TA, Cooter RD, Gold M. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-71.
57. Blackburn WR, Cosman B. Histologie basis of keloid and hypertrophic scar differentiation. Arch Pathol. 1996;82:65-71.
58. Pavlova MN. Morfogenez keloidnykh rubtsov u ozhogovykh bol'nykh. Dis. … d-ra med. nauk. Moscow, 1970 (in Russian).
59. Beausang E, Floyd H, Dunn K, et al. A new quantitative scale for clinical scar assessment. Plast Reconstr Surg. 1998;102:1954-61.
60. Westerhof W. CIE colorimetry. In: Ed. J Serup, GBE Jemec. Handbook of non-invasive methods and the skin. CRC Press: Boca Raton, Fla., 1995; p. 385-97.
61. Ketchum LD, Smith J, Robinson DW, Masters FW. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg. 1966;38(3):209-18. DOI:10.1097/00006534-196609000-00005
62. Roques C, Teot L, Frasson N, Meaume S. PRIMOS: an optical system that produces three-dimensional measurements of skin surfaces. J Wound Care. 2003;12:62-4.
63. Draaijers LJ, Botman YA, Tempelman FR, et al. Skin elasticity meter or subjective evaluation in scars: a reliability assessment. Burns. 2004;30(2):109-14. DOI:10.1016/j.burns.2003.09.003
64. Sullivan T, Smith J, Kermode J, et al. Rating the Burn Scar. J Burn Care Rehabil. 1990;11(3):256-60. DOI:10.1097/00004630-199005000-00014
65. Yeong EK, Mann R, Engrav LH, et al. Improved burn scar assessment with use of a new scar-rating scale. J Burn Care Rehabil. 1997;18:353-5.
66. Kantor J. Reliability and Photographic Equivalency of the Scar Cosmesis Assessment and Rating (SCAR) Scale, an Outcome Measure for Postoperative Scars. JAMA Dermatol. 2017;153(1):55-60. DOI:10.1001/jamadermatol.2016.3757
67. Singer AJ, Arora B, Dagum A, et al. Development and Validation of a Novel Scar Evaluation Scale. Plast Recon Sur. 2007;120(7):1892-7. DOI:10.1097/01.prs.0000287275.15511.10
68. (in Russian)
69. Furtado F, Hochman B, Ferreira LM. Evaluating keloid recurrence after surgical excision with prospective longitudinal scar assessment scales. JPRAS. 2012;65(7):175-81.
70. Alster TS, West TB. Treatment of scars: a review. Ann Plast Surg. 1997;39(4):418-32. 
71. Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumpedpulsed-dyelaser. Lancet. 1995;345(8959):1198-2000.
72. Belousov AE. Essays on Plastic Surgery. Vol. 1. Scars and their correction. Saint Petersburg, 2005 (in Russian).
73. Sherris DA, Larrabee WF, Murakami CS. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am. 1995;28:1057-68.
74. Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg. 1996;22:1267-130.
75. Berman B, Bieley HC. Keloids. J Am Acad Dermatol. 1995;33:117-23.
76. Shin JY, Lee JW, Roh SG, et al. A Comparison of the Effectiveness of Triamcinolone and Radiation Therapy for Ear Keloids after Surgical Excision: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2016;137(6):1718-25. DOI:10.1097/PRS.0000000000002165
77. Shafranov VV, Reznitskii VG. Nekotorye problemy i perspektivy ispol'zovaniia nizkikh temperatur v detskoi khirurgii. Vestnik AMN SSSR. 1984;9 (in Russian). 
78. Sproat JE, Dalcin A, Weitauer N, Roberts RS. Hypertrophic sternal scars: silicone gel sheeting versus kenalog injection treatment. Plast Reconstr Surg. 1992;90:988-92.
79. Friedman SJ, Butler DF, Pittelkow MR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy: Report of two cases and review of the literature. J Am Acad Dermatol. 1988;19:537-41.
80. Mann T, Scherner C, Röhm KH, Kolbe L. Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase. Int J Mol Sci. 2018;19(3):690. DOI:10.3390/ijms19030690 
81. Mann T, Gerwat W, Batzer J, et al. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase. J Invest Dermatol. 2018;138(7):1601-8. DOI:10.1016/j.jid.2018.01.019
82. Arrowitz C, Schoelermann AM, Mann T, et al. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma. J Invest Dermatol. 2019;139(8):1691-8.e6. DOI:10.1016/j.jid.2019.02.013
83. Krupashankar DS. IADVL Dermatosurgery Task Force. Standard guidelines of care: CO2 laser for removal of benign skin lesions and resurfacing. Indian J Dermatol Venerol Leprol. 2008;74:61-7.
84. Weinhammer AP, Shields BE, Keenan T. Intralesional corticosteroid-induced hypopigmentation and atrophy. Dermatol Online J. 2020;26(1):13030/qt0bj81707. PMID: 32155037.
85. Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg. 1995;21(8):685-7. DOI:10.1111/j.1524-4725.1995.tb00270.x
86. Wittenberg GP, Fabian BG, Bogomilsky JL. Prospective single-blind, randomised controlled study to assess the efficacy of the 585-nm flashlamp pumped pulsed-dye laser and silicone gel sheeting in hypertrophic scar treatment. Arch Dermatol. 1999;135(9):1049-55.
87. Alster TS, Tanzi EL. Hypertrophic scars and keloids etiology and management. Am J Clin Dermatol. 2003;4:235-43.
88. Mankowski P, Kanevsky J, Tomlinson J, et al. Optimizing Radiotherapy for Keloids: A Meta-Analysis Systematic Review Comparing Recurrence Rates Between Different Radiation Modalities. Ann Plast Surg. 2017;78(4):403-11. DOI:10.1097/SAP.0000000000000989
89. Van de Kar AL, Kreulen M, van Zuijlen PP, Oldenburger F. The results of surgical excision and adjuvant irradiation for therapy-resistant keloids: A prospective clinical outcome study. Plast Reconstr Surg. 2007;119:2248-54.
90. Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: Retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111:547-53.
91. De las Alas JM, Siripunvarapon AH, Dofitas BL. Pulsed dye laser for the treatment of keloid and hypertrophic scars: a systematic review. Expert Rev Med Devices. 2012;9(6):641-50. DOI:10.1586/erd.12.56
92. Ellis MM, Jones LR, Siddiqui F, et al. The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis. Dermatol Surg. 2020;46(8):1054-59. DOI:10.1097/DSS.0000000000002362
93. Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg. 1991;27(2):164-78. DOI:10.1097/00000637-199108000-00012 
94. Clugston PA, Vistnes MD, Perry LC. Evaluation of silicone-gel sheeting on early wound healing of linear incisions. Ann Plast Surg. 1995;34:12-5.
95. Roderick BJ, Joyce D, Wasil K, et al. Splints and scar management for acute and reconstructive burn care. Clin Plast Surg. 2000;1:71-85.
96. Monstrey S, Middelkoop E, Vranckx JJ, et al. Updated Scar Management Practical Guidelines: Non-invasive and invasive measures. J Plast Reconstr Aesthet Surg. 2014;67(8):1017-25. DOI:10.1016/j.bjps.2014.04.011
97. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol. 1994;30:506-7.
98. Katz BE. Silicone gel sheeting in scar therapy. Cutis. 1995;56:65-7.
99. Tredget EE, Wang R, Shen Q, et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res. 2000;20:143-51.
100. Grandstein RD, Rook A, Flotte TJ. A controlled trial of intralesional recombinant interferon у in the treatment of keloid scarring. Arch Dermatol. 1990;126:1285-302.
101. Berman B, Dunan MR. Short-term keloid treatment in vivo with human interferon α 2b results in a selective and persistent normalization of keloid fibroblast collagen, glycosaminoglycan and collagenase production in vitro. J Am Acad Dermatol. 1989;21:694-702.
102. Goldan O, Weissman O, Regev E, et al. Treatment of postdermabrasion facial hypertrophic and keloid scars with intralesional 5-Fluorouracil injections. Aesthetic Plast Surg. 2008;32(2):389-92. DOI:10.1007/s00266-007-9109-3
103. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol. 2004;45(2):140-3. DOI:10.1111/j.1440-0960.2004.00072.x
104. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology. 2002;204(2):130-2. DOI:10.1159/000051830
105. Cosman B, Crikelair GF, Ju MC. The surgical treatment of keloids. Plast Reconstr Surg. 1961;27:335-58.
106. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg. 1999;25:224-32.
107. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: Comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nmflashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 1992;138:1149-55.
108. Bodokh I, Brun P. The treatment of keloids with intralesional Bleomycin. Ann Dermatol Venereol. 1996;123:791-4.
109. Shafranov VV, Borkhunova EN, Taganov AV, et al. Keloid scars. New treatment technologies. Part 2. Moscow: RANS, 2009 (in Russian).
110. Tsyganov DI. Thermophysical aspects of cryosurgery. Moscow: RMA-PO, 2005 (in Russian). 
111. Tsyganov DI, Shafranov VV, Butorina AV. Teoreticheskie aspekty primeneniia novykh tekhnicheskikh sredstv v kriokhirurgii. Nauka i tekhnologii v Rossii. 1998;6:20-1 (in Russian). 
112. Shafranov VV, Borkhunova EN, Taganov AV, Korotkiy NG. Keloid Scars in Children. A Guide for Physicians. Moscow: Dynasty, 2006 (in Russian).
113. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993;19(6):529-34.
114. Paches AI. Cryogenic method for the treatment of head and neck tumors. Moscow, 1978 (in Russian). 
115. Rikberg AV, Trushkevich LI. About the possibility of strengthening cryopreservation. In: Mechanisms and cryopreservation of biological structures. Kiev, 1976; p. 116-8 (in Russian).
116. Borkhunova EN. Osobennosti reparativnoi regeneratsii tkanei posle kriodestruktsii, SVCh-kriodestruktsii i SVCh-destruktsii. Dis. … d-ra med. nauk. Moscow, 2004 (in Russian).
117. Sizov VM, Pechenova TN, Volodina TG, et al. Changes in the structure of postburn keloid scars before and after cryotherapy. Vrach Delo. 1990;(9):95-7 (in Russian). PMID: 2284788.
118. Taganov AV. Sovremennye tekhnologii v lechenii rubtsovykh gipertrofii. Eksperimental'noe i kliniko-morfologicheskoe issledovanie. Dis …. d-ra med. nauk. Moscow, 2010 (in Russian). 
119. Pis'menskova AV. Lechenie keloidnykh rubtsov metodom SVCh-destruktsii v dermatokosmetologicheskoi praktike. Dis. … kand. med. nauk. Moscow, 2010 (in Russian).
120. Stewart CE, Kim JY. Application of mitomycin-C for head and neck keloids. Otolaryngol Head Neck Surg. 2006;135:946-50.

А.В. Таганов*1, А.В. Брагина2

1 ФГАОУ ВО «Российский университет дружбы народов», Москва, Россия;
2 ООО «Инсайд Бьюти», Москва, Россия
*matis87177@yandex.ru

________________________________________________

Aleksei V. Taganov*1, Anastasiia V. Bragina2

1 People’s Friendship University of Russia (RUDN University), Moscow, Russia;
2 LLC “Inside Beauty”, Moscow, Russia
*matis87177@yandex.ru